Aptose Non Current Assets Total vs Total Stockholder Equity Analysis

APTO Stock  USD 0.39  0.02  5.41%   
Aptose Biosciences financial indicator trend analysis is way more than just evaluating Aptose Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aptose Biosciences is a good investment. Please check the relationship between Aptose Biosciences Non Current Assets Total and its Total Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.

Non Current Assets Total vs Total Stockholder Equity

Non Current Assets Total vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aptose Biosciences Non Current Assets Total account and Total Stockholder Equity. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Aptose Biosciences' Non Current Assets Total and Total Stockholder Equity is 0.46. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Aptose Biosciences, assuming nothing else is changed. The correlation between historical values of Aptose Biosciences' Non Current Assets Total and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Aptose Biosciences are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Non Current Assets Total i.e., Aptose Biosciences' Non Current Assets Total and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.46
Relationship DirectionPositive 
Relationship StrengthWeak

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from Aptose Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aptose Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.At this time, Aptose Biosciences' Selling General Administrative is very stable compared to the past year. As of the 31st of October 2024, Sales General And Administrative To Revenue is likely to grow to 47.11, while Issuance Of Capital Stock is likely to drop about 5.8 M.
 2021 2022 2023 2024 (projected)
Net Interest Income94K788K1.4M1.5M
Interest Income94K788K1.4M1.5M

Aptose Biosciences fundamental ratios Correlations

0.090.250.990.74-0.97-0.390.340.960.550.641.00.510.560.11-0.30.370.280.081.0-0.02-0.190.930.470.020.72
0.090.95-0.040.44-0.06-0.850.690.10.67-0.120.060.86-0.010.080.870.880.940.910.080.86-0.220.370.81-0.040.53
0.250.950.120.63-0.22-0.930.870.250.78-0.030.230.940.090.230.720.961.00.810.240.91-0.270.470.88-0.040.69
0.99-0.040.120.67-0.96-0.270.230.960.460.660.990.40.560.08-0.40.250.15-0.020.99-0.14-0.160.890.370.020.64
0.740.440.630.67-0.71-0.630.740.720.850.490.730.730.330.320.080.640.650.430.740.46-0.090.750.7-0.040.81
-0.97-0.06-0.22-0.96-0.710.34-0.32-1.0-0.54-0.73-0.97-0.46-0.34-0.160.28-0.3-0.24-0.11-0.970.070.2-0.91-0.45-0.06-0.66
-0.39-0.85-0.93-0.27-0.630.34-0.83-0.37-0.72-0.11-0.36-0.95-0.21-0.25-0.55-0.93-0.93-0.66-0.38-0.810.55-0.57-0.94-0.13-0.84
0.340.690.870.230.74-0.32-0.830.340.780.080.320.840.120.410.390.860.880.510.330.86-0.250.440.77-0.10.72
0.960.10.250.960.72-1.0-0.370.340.570.730.960.490.330.17-0.240.330.280.150.96-0.04-0.210.920.470.070.66
0.550.670.780.460.85-0.54-0.720.780.570.340.530.80.160.240.380.750.80.660.550.62-0.140.660.790.040.65
0.64-0.12-0.030.660.49-0.73-0.110.080.730.340.650.170.030.49-0.310.030.00.080.64-0.31-0.150.590.250.20.37
1.00.060.230.990.73-0.97-0.360.320.960.530.650.490.560.1-0.320.340.250.061.0-0.05-0.180.920.450.020.7
0.510.860.940.40.73-0.46-0.950.840.490.80.170.490.270.160.520.970.940.70.510.79-0.310.670.93-0.040.84
0.56-0.010.090.560.33-0.34-0.210.120.330.160.030.560.27-0.12-0.330.250.1-0.170.560.01-0.050.490.2-0.150.43
0.110.080.230.080.32-0.16-0.250.410.170.240.490.10.16-0.12-0.040.160.240.120.110.12-0.30.140.240.220.24
-0.30.870.72-0.40.080.28-0.550.39-0.240.38-0.31-0.320.52-0.33-0.040.560.70.89-0.310.71-0.130.010.49-0.130.12
0.370.880.960.250.64-0.3-0.930.860.330.750.030.340.970.250.160.560.960.690.360.84-0.220.540.88-0.030.77
0.280.941.00.150.65-0.24-0.930.880.280.80.00.250.940.10.240.70.960.810.270.91-0.270.490.88-0.050.7
0.080.910.81-0.020.43-0.11-0.660.510.150.660.080.060.7-0.170.120.890.690.810.080.65-0.110.380.67-0.070.37
1.00.080.240.990.74-0.97-0.380.330.960.550.641.00.510.560.11-0.310.360.270.08-0.03-0.190.930.470.010.72
-0.020.860.91-0.140.460.07-0.810.86-0.040.62-0.31-0.050.790.010.120.710.840.910.65-0.03-0.210.160.72-0.150.51
-0.19-0.22-0.27-0.16-0.090.20.55-0.25-0.21-0.14-0.15-0.18-0.31-0.05-0.3-0.13-0.22-0.27-0.11-0.19-0.21-0.29-0.47-0.48-0.45
0.930.370.470.890.75-0.91-0.570.440.920.660.590.920.670.490.140.010.540.490.380.930.16-0.290.660.030.77
0.470.810.880.370.7-0.45-0.940.770.470.790.250.450.930.20.240.490.880.880.670.470.72-0.470.660.240.82
0.02-0.04-0.040.02-0.04-0.06-0.13-0.10.070.040.20.02-0.04-0.150.22-0.13-0.03-0.05-0.070.01-0.15-0.480.030.240.12
0.720.530.690.640.81-0.66-0.840.720.660.650.370.70.840.430.240.120.770.70.370.720.51-0.450.770.820.12
Click cells to compare fundamentals

Aptose Biosciences Account Relationship Matchups

Aptose Biosciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets100.5M126.3M82.5M51.0M12.9M12.3M
Other Current Liab3.1M4.1M6.0M5.7M13.9M14.6M
Total Current Liabilities5.5M6.8M8.2M12.3M15.2M16.0M
Total Stockholder Equity93.9M118.9M74.2M37.7M(2.9M)(2.7M)
Property Plant And Equipment Net1.7M1.2M788K1.5M1.1M574.3K
Net Debt(78.3M)(116.3M)(38.5M)(35.7M)(8.2M)(8.6M)
Retained Earnings(301.9M)(357.2M)(422.5M)(464.3M)(512.9M)(487.3M)
Accounts Payable2.0M2.2M1.7M6.3M3.5M3.7M
Cash79.8M117.4M39.1M37.0M9.2M15.8M
Non Current Assets Total1.7M1.2M788K1.5M1.1M1.7M
Cash And Short Term Investments97.6M122.4M79.1M47.0M9.2M8.7M
Common Stock Shares Outstanding3.3M5.5M5.9M6.2M6.8M7.1M
Short Term Investments798K440K17.8M5M40.0M10.0M
Liabilities And Stockholders Equity100.5M126.3M82.5M51.0M12.9M12.3M
Non Current Liabilities Total1.0M535K115K1.0M617.8K586.9K
Other Current Assets141K129K133K257K2.6M2.8M
Other Stockholder Equity34.6M50.9M63.7M68.9M71.8M75.4M
Total Liab6.6M7.3M8.3M13.3M15.8M16.6M
Property Plant And Equipment Gross1.7M1.2M323K211K3.9M4.1M
Total Current Assets98.8M125.1M81.7M49.5M11.8M11.2M
Non Currrent Assets Other(94.0)(48.0)465K1.3M1.2M1.2M
Intangible Assets1.0142.094.048.043.241.04
Net Tangible Assets93.8M118.9M74.2M37.7M43.4M45.6M
Common Stock Total Equity365.5M429.5M437.4M437.5M503.1M528.3M
Retained Earnings Total Equity(301.9M)(357.2M)(422.5M)(464.3M)(417.9M)(397.0M)
Common Stock365.5M429.5M437.4M437.5M442.5M231.4M
Property Plant Equipment1.6M1.1M788K211K189.9K364.1K
Capital Surpluse34.6M50.9M63.7M68.9M79.2M51.4M
Net Invested Capital93.9M118.9M74.2M37.7M(2.9M)(2.8M)
Net Working Capital93.2M118.3M73.6M37.2M(3.4M)(3.2M)
Capital Stock365.5M429.5M437.4M437.5M444.8M435.6M

Pair Trading with Aptose Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aptose Stock

  0.64MBIO Mustang BioPairCorr
  0.75MNMD Mind MedicinePairCorr

Moving against Aptose Stock

  0.56BMY Bristol Myers SquibbPairCorr
  0.52MLYS Mineralys Therapeutics,PairCorr
  0.51FLGC Flora Growth CorpPairCorr
  0.5EWTX Edgewise TherapeuticsPairCorr
  0.36EXEL Exelixis Upward RallyPairCorr
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Aptose Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aptose Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aptose Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aptose Biosciences Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptose Biosciences. If investors know Aptose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptose Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.24)
Return On Assets
(1.36)
Return On Equity
(6.94)
The market value of Aptose Biosciences is measured differently than its book value, which is the value of Aptose that is recorded on the company's balance sheet. Investors also form their own opinion of Aptose Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aptose Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptose Biosciences' market value can be influenced by many factors that don't directly affect Aptose Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.